Skip to content

Thermal Management in Patients With Interventional Minimally Invasive Valve Replacement

A Randomized Pilot Study for Thermal Management in Patients With Interventional Minimally Invasive Valve Replacement

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01176110
Acronym
TIMI
Enrollment
40
Registered
2010-08-05
Start date
2010-07-31
Completion date
2011-05-31
Last updated
2011-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Temperature, Outcomes

Keywords

hypothermia, minimal invasive valve replacement

Brief summary

It is known that perioperative hypothermia can influence the postoperative outcome negatively. The most important complications are cardiac, increased blood loss with need for transfusion and a significantly increased wound infection rate. The thermal redistribution after the induction of anesthesia is on of the reasons for perioperative hypothermia. Another reason is negative heat balance during surgery. Further negative side effects of hypothermia are an increase of blood viscosity and thus a higher risk for thrombosis, coagulopathy and thus an increased risk of bleeding. The aim of the study is to evaluate if patients with a perioperative active thermal management during an interventional minimal invasive valve replacement have a significantly higher body temperature at the end of the operation than patients without an active thermal management. Secondary outcome variables are complication rates, length of mechanical ventilation and length of ICU treatment.

Interventions

DEVICELMA Perfect Temp

The LMA PerfecTemp™ patient warming system combines warming beneath the patient and advanced pressure reduction to combat hypothermia and decubitus ulcers. This device is used during the interventional minimal invasive valve replacement with unprecedented ease and safety

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients, who need an interventional minimal invasive valve replacement * Age ≥ 18 years * scheduled general anesthesia during intervention * no participation on another interventional study * signed informed consent

Exclusion criteria

* pregnant or breast feeding women * non-elective intervention * conversion to HLM * implantation of IABP * pre-existing decubitus * patients who are not able to sign informed consent

Design outcomes

Primary

MeasureTime frameDescription
Temperature at the end of the interventionaverage 2 hoursThe end of the surgical procedure is defined and is recorded for all patients in the hospital information systems. This time point will be used to record the body temperature at the end of the intervention

Secondary

MeasureTime frameDescription
hospital staymax 28 days
mechanical ventilation timemaximum 28 daysThe mechanical ventilation time in the hospital is recorded electronically. The time frame will be recorded as the outcome measure in this study.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026